CD8A and neoplasm: A dendritic cell vaccine transfected with CD133 mRNA was shown to attenuate the stemness of CSCs by upregulating the expression of CD8+ TILs in TNBC in mice, in turn inhibiting tumor growth and causing longer survival time [82].